TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

OpSens To Participate In The Piper Sandler 32nd Annual Virtual Healthcare Conference

  • By PR Newswire
  • Nov 24, 2020 12:24 PM EST
PRESS RELEASES

OpSens Recognized As One Of The Fastest-Growing Company In North America On Deloitte's 2020 Technology Fast 500™

  • By PR Newswire
  • Nov 18, 2020 11:00 AM EST
PRESS RELEASES

OpSens To Host Year-End Update Conference Call On Thursday, November 19, 2020

  • By PR Newswire
  • Nov 12, 2020 9:00 AM EST
PRESS RELEASES

OpSens Awarded Contract By Major U.S. Group Purchasing Organization

  • By PR Newswire
  • Oct 14, 2020 7:00 AM EDT
PRESS RELEASES

OpSens To Present At Lytham Partners Virtual Investor Growth Conference

  • By PR Newswire
  • Sep 30, 2020 9:00 AM EDT
PRESS RELEASES

OpSens - 100,000 Cases Performed With The OptoWire

  • By PR Newswire
  • May 20, 2020 9:04 AM EDT
PRESS RELEASES

OpSens Provides Operational Update - OpSens Continues To Supply Essential Cardiovascular Solutions To Patients Around The World

  • By PR Newswire
  • Mar 24, 2020 7:00 AM EDT
PRESS RELEASES

Opsens Receives FDA Approval Of Optowire III

  • By PR Newswire
  • Jan 13, 2020 9:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.